Unsurprisingly, over 72% of target companies acquired were US-based, with 14%  out of Europe, 7% out of Canada, and the remaining 7% distributed among other countries. Additionally, the majority of HealthTech buyers are based in North America as well–with  68% from the US and 11% from Canada.